Changes in Beneficial Ownership · 4
STERIS plc
STENYSEEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1786566834.xml
Filing details
- Report period
- 2026-08-10
- Issuer
- STERIS plc
- Issuer CIK
- 0001757898
- Trading symbol
- STE
Reporting owner 1
- Name
- Sohi Mohsen
- Reporting owner CIK
- 0001293588
- Relationship
- Director
- Address
- 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND, L2, D02 R296
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | 2026-08-12 | M · Form 4 | 4,058 | A | 86.23 | 28,363 | D |
| Ordinary Shares | 2026-08-12 | S · Form 4 | 4,058 | D | 235.78[F1] | 24,305 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
- S · Form 4
- Sale on the market or privately
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy) | 238.91 | 2026-08-10 | A · Form 4 | 1,099 | A | 0 | [F2] | 2036-08-10 | Ordinary Shares | 1,099 | 1,099 | D |
| Career Restricted Stock Units | [F3] | 2026-08-10 | A · Form 4 | 1,229 | A | 0 | [F4] | [F4] | Ordinary Shares | 1,229 | 8,979 | D |
| Director Stock Option (right to buy) | 86.23 | 2026-08-12 | M · Form 4 | 4,058 | D | 0 | [F5] | 2027-08-09 | Ordinary Shares | 4,058 | 0 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
Footnotes
- F1
- Price reflects a weighted average sale price for multiple transactions ranging from $235.73 to $235.89 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.↩ 1
- F2
- These nonqualified stock options are fully vested and are exercisable immediately.↩ 1
- F3
- Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.↩ 1
- F4
- These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.↩ 1↩ 2
- F5
- This option to purchase 4,058 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 4,058 ordinary shares for $86.23 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.↩ 1
Signature 1
- Signed
- /s/ John P. Ubbing, Authorized Representative under Power of Attorney
- Date
- 2026-08-12
Company context
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. For more information, visit www.steris.com.
Current securities
Recent company filings
- 10-Q filingNov 5, 2026
- Entry into a Material Definitive Agreement · Termination of a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementNov 4, 2026
- Results of Operations and Financial Condition · Costs Associated with Exit or Disposal ActivitiesNov 4, 2026
- Entry into a Material Definitive AgreementOct 13, 2026
- 4 filingOct 5, 2026